Additionally, several studies revealed that the higher expression of DEPDC1 was significantly correlated with poorer survival of patients in hepatocellular carcinoma and multiple myeloma, indicating that DEPDC1 might be a new diagnostic marker (11, 14). This evidence concerns the gene DEPDC1 and AL amyloidosis.